Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2012 | 03-2011 | 03-2010 | 03-2009 | 03-2008 | |
| Sales | 126,375 | 101,151 | 85,713 | 73,210 | 58,941 |
| Cost of Goods | 24,507 | 21,977 | 22,529 | 20,437 | 15,065 |
| Gross Profit | 101,868 | 79,174 | 63,184 | 52,773 | 43,876 |
| Operating Expenses | 100,855 | 91,336 | 88,789 | 82,728 | 80,428 |
| Operating Income | 1,520 | -11,185 | -25,076 | -29,518 | -36,487 |
| Other Income | 1,023 | 322 | 6,723 | -1,327 | -3,916 |
| Pre-tax Income | 2,543 | -10,863 | -18,353 | -30,845 | -40,403 |
| Income Tax | 1,048 | 892 | 671 | 752 | 527 |
| Net Income Continuous | 1,495 | -11,755 | -19,024 | -31,597 | -40,930 |
| Net Income | $1,495 | $-11,755 | $-19,024 | $-31,597 | $-40,930 |
| EPS Basic Total Ops | 0.04 | -0.32 | -0.52 | -0.91 | -1.26 |
| EPS Basic Continuous Ops | 0.04 | -0.32 | -0.52 | -0.91 | -1.26 |
| EPS Diluted Total Ops | 0.04 | -0.32 | -0.52 | -0.91 | -1.26 |
| EPS Diluted Continuous Ops | 0.04 | -0.32 | -0.52 | -0.91 | -1.26 |
| EBITDA(a) | $5,856 | $-7,237 | $-20,178 | $-24,502 | $-30,363 |